Advances in Sleep Pharmaceuticals (Technical Insights)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service outlines the key developments in the field of sleep pharmaceuticals

Table of Contents

Advances in Sleep Pharmaceuticals (Technical Insights), Executive SummaryScope and MethodologyScopeMethodologyIndustry OverviewIntroductionCurrent ScenarioKey DevelopmentsAdvances in Sleep Pharmaceuticals (Technical Insights), Technology Adoption Factor AnalysisTech PrimerThe Physiology of SleepThe Functions of SleepCommon Sleep DisordersA Peek into Sleep Assessment MethodsDrivers and ChallengesTechnology DriversTechnological Roadblocks Assessment of Market TrendsAnalysis and InsightsSWOT AnalysisAnalysis of Evolution of Sleep TherapeuticsAnalysis of Drug TargetsAnalyst Insights and Strategic RecommendationsOther Important Must-KnowsFunding OpportunitiesRegulatory IssuesRecent Key AcquisitionsAdvances in Sleep Pharmaceuticals (Technical Insights), Research and Development Highlights in Companies and UniversitiesCompaniesAn Inverse Serotonin Receptor Agonist for Chronic Insomnia--USAAn Old Drug Put to a New Use with a New Mechanism--USAA Truly Novel Target Harnessed for the Treatment of Sleep Disorders--SwitzerlandFor the First Time a Combination Therapy for Sleep Apnea--UKA Circadi(a)n Solution--IsraelOld Receptor--New Binding Site--USAA Melatonin-Acting Agent for Insomnia and a Drug of Unknown Mechanism for EDS--USAA Transported Prodrug to Treat RLS--USAA Novel Dual-Acting Drug for Insomnia--USAOrphan Receptors--Potential Drug Targets for Sleep Disorders--USAUniversitiesLeukotriene Receptor Antagonist Could Work for Mild Sleep Apnea in Children--USAAntiepileptic Agent Proves Useful for Dopaminergic Drug Resistant RLS--SpainResearchers Investigate Downstream of Hypocretin Receptor in Narcoleptic Dogs--SwedenVitamin C Could Ameliorate Cardiovascular Morbidity Associated with OSA--GermanyScientists Try to Decipher Connection between Feeding and Sleep--HungaryAdvances in Sleep Pharmaceuticals (Technical Insights), Key Patents; Contacts; and GlossaryKey PatentsInsomniaRestless Legs SyndromeNarcolepsyDetails of Key ParticipantsCompaniesUniversitiesGlossaryKey DefinitionsAbbreviationsAdvances in Sleep Pharmaceuticals (Technical Insights), Decision Support DatabaseDatabase TablesTotal Healthcare Expenditure--World (1999 to 2006)Pharma R&D Expenditure--World (1999 to 2006)Percentage of Pharma R&D Expenditure--World (1999 to 2006)Prevalence of Dementia--World (1999 to 2006)Dementia Mortality--World (1999 to 2006)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.